Novartis AG (NVS)

Growth

Revenue 5Y-
Revenue 3Y-
EPS 5Y-
EPS 3Y-
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC-
ROE-
ROA-
ROTA-

Capital Structure

Market Cap180.93B
EV180.93B
Cash-
Current Ratio-
Debt/Equity-
Net Debt/EBITDA-
Show More

Ratios

Select a metric from the list below to chart it

Dec '98
Dec '03
Dec '08
Dec '13
Dec '18
Ratios
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Price to Book Ratio
2.4
3.0
2.2
2.1
2.6
2.3
4.0
3.6
2.8
3.1
Price to Book Ratio % Chg.
10.0%
27.2%
-27.2%
-5.5%
26.2%
-12.9%
74.9%
-8.1%
-21.7%
7.9%
Price to Earnings Ratio
19.1
20.7
9.4
23.0
25.0
14.1
18.7
25.5
8.0
8.6
Price to Earnings Ratio % Chg.
22.6%
8.8%
-54.5%
143.1%
9.0%
-43.6%
32.7%
36.2%
-68.6%
6.9%
Price to Free Cash Flow Ratio
18.2
20.2
20.0
17.9
19.5
16.3
19.3
18.6
15.9
17.0
Price to Free Cash Flow Ratio % Chg.
37.1%
10.8%
-0.9%
-10.4%
8.9%
-16.4%
18.5%
-3.7%
-14.5%
6.7%
Price to Operating Cash Flow Ratio
13.3
15.2
14.1
13.4
15.3
12.5
16.1
15.1
12.8
13.3
Price to Operating Cash Flow Ratio % Chg.
27.5%
14.8%
-7.4%
-4.9%
13.7%
-18.3%
29.3%
-6.4%
-15.3%
4.4%
Price Earnings to Growth Ratio
-4.4
1.7
0.1
-0.4
1.5
0.2
-3.2
-0.8
0.0
0.1
Price Earnings to Growth Ratio % Chg.
-
-
-92.8%
-
-
-86.0%
-
73.9%
-
239.3%
Price to Sales Ratio
3.0
3.9
3.3
3.1
3.8
3.3
4.5
4.1
3.6
3.6
Price to Sales Ratio % Chg.
15.8%
32.8%
-15.6%
-6.5%
23.4%
-12.9%
34.8%
-8.6%
-11.7%
-1.8%
EV to EBITDA
11.5
12.8
7.4
11.7
13.4
9.1
11.7
13.5
6.4
6.6
EV to EBITDA % Chg.
18.8%
11.4%
-42.1%
58.2%
14.4%
-32.2%
28.6%
15.6%
-52.6%
3.8%